KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Operating Leases (2018 - 2025)

Biogen has reported Operating Leases over the past 8 years, most recently at $290.4 million for Q4 2025.

  • Quarterly results put Operating Leases at $290.4 million for Q4 2025, down 13.18% from a year ago — trailing twelve months through Dec 2025 was $290.4 million (down 13.18% YoY), and the annual figure for FY2025 was $290.4 million, down 13.18%.
  • Operating Leases for Q4 2025 was $290.4 million at Biogen, down from $305.0 million in the prior quarter.
  • Over the last five years, Operating Leases for BIIB hit a ceiling of $490.3 million in Q4 2023 and a floor of $274.2 million in Q2 2022.
  • Median Operating Leases over the past 5 years was $351.5 million (2021), compared with a mean of $356.4 million.
  • Peak annual rise in Operating Leases hit 24.31% in 2024, while the deepest fall reached 31.78% in 2024.
  • Biogen's Operating Leases stood at $419.5 million in 2021, then rose by 2.55% to $430.2 million in 2022, then rose by 13.97% to $490.3 million in 2023, then plummeted by 31.78% to $334.5 million in 2024, then dropped by 13.18% to $290.4 million in 2025.
  • The last three reported values for Operating Leases were $290.4 million (Q4 2025), $305.0 million (Q3 2025), and $310.9 million (Q2 2025) per Business Quant data.